What is the recommended use and dosage of doxepin (Sinequan) for treating depression, anxiety, and insomnia?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 5, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Doxepin (Sinequan) Dosage and Usage for Depression, Anxiety, and Insomnia

For depression, doxepin should be initiated at 75 mg/day and titrated to an optimal dose range of 75-150 mg/day, with a maximum of 300 mg/day if necessary. For insomnia, low-dose doxepin at 3-6 mg is recommended. 1

Dosing Guidelines for Different Conditions

Depression

  • Initial dose: 75 mg daily for mild to moderate depression 1
  • Maintenance dose: 75-150 mg/day (optimal range) 1
  • Severe cases: May increase gradually to 300 mg/day if necessary 1
  • Mild cases: Some patients respond to doses as low as 25-50 mg/day 1
  • Administration: Can be given as a divided dose or once daily (if once daily, maximum 150 mg at bedtime) 1

Anxiety

  • Dosing: Similar to depression dosing (75-150 mg/day) 1
  • Onset of effect: Anti-anxiety effects typically appear before antidepressant effects 1
  • Advantage: More effective than benzodiazepines when anxiety is accompanied by significant depression 2

Insomnia

  • Recommended dose: 3-6 mg for sleep maintenance insomnia 3
  • Evidence: Low-dose doxepin (3-6 mg) has demonstrated efficacy for sleep maintenance with minimal side effects 4, 5
  • Comparison: At 12.5 mg/day, doxepin significantly improved sleep latency compared to citalopram in patients with comorbid insomnia and anxiety 6
  • Duration: Effective for both short-term and long-term management of insomnia 7

Administration Guidelines

  • Once-daily dosing: If using once-daily schedule, maximum dose is 150 mg/day, preferably at bedtime 1
  • Divided dosing: May be used for higher total daily doses 1
  • Maintenance: The 150 mg capsule strength is intended for maintenance therapy only, not for treatment initiation 1
  • Treatment duration:
    • For depression: Optimal antidepressant effect may take 2-3 weeks to appear 1
    • For insomnia: Can be used for up to 3 months with minimal tolerance development 5

Special Populations

Elderly Patients

  • Starting dose: Use lower doses (start at low end of dosing range) 1
  • Monitoring: Observe closely for confusion and oversedation 1
  • Caution: Greater risk of anticholinergic effects, falls, and cardiac effects 1

Patients with Renal Impairment

  • Dosing: Use caution in dose selection due to unknown renal excretion profile 1
  • Monitoring: Monitor for increased side effects 1

Side Effects and Precautions

Common Side Effects

  • CNS: Drowsiness (most common, tends to diminish with continued therapy) 1
  • Anticholinergic: Dry mouth, blurred vision, constipation, urinary retention 1
  • Cardiovascular: Occasional hypotension, hypertension, tachycardia 1
  • Gastrointestinal: Nausea, vomiting, indigestion 1

Serious Adverse Effects

  • Cardiac: Risk of QT prolongation, especially in patients with cardiac conditions 3
  • Withdrawal: Gradual tapering recommended to prevent withdrawal symptoms 1
  • Overdose risk: Can cause cardiac dysrhythmias, severe hypotension, convulsions, and CNS depression 1

Comparative Efficacy

  • Depression: Similar mood-elevating effect to amitriptyline but possibly less marked than imipramine 2
  • Anxiety with depression: More effective than benzodiazepines like chlordiazepoxide or diazepam 2
  • Insomnia: Low-dose doxepin (3-6 mg) improves sleep efficiency and maintenance with minimal effects on sleep architecture 5, 7

Practical Considerations

  • Depression onset: Therapeutic effect may take 2-3 weeks to become fully evident 1
  • Insomnia treatment: Consider as an alternative when non-benzodiazepine hypnotics are contraindicated 4
  • Advantage over other TCAs: At therapeutic doses, doxepin causes fewer cardiovascular side effects than other tricyclics, making it better tolerated by elderly patients and those with cardiovascular disease 2
  • Monitoring: Regular follow-up is essential, especially during the initial weeks of treatment

Contraindications and Warnings

  • Glaucoma: Use with caution due to anticholinergic effects 1
  • Cardiovascular disease: Monitor for cardiac effects, though better tolerated than other tricyclics 2
  • Abrupt discontinuation: Avoid sudden cessation after prolonged use; taper gradually 1
  • Concomitant medications: Use caution with other CNS depressants or anticholinergic medications 1

Doxepin offers versatility in treating multiple conditions with its sedative and antidepressant properties, but dosing must be carefully tailored to the specific condition being treated, with much lower doses effective for insomnia than for depression or anxiety.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.